Rallybio Corporation (RLYB)

Rallybio Corporation (RLYB) is a healthcare company (biotechnology) based in the United States. The share price is $15.34, down 0.58% on the day, which values the company at $85.88M. Price as of 17 Nov 2026, 17:41 UTC, from Yahoo Finance.

Key facts

Share price
$15.34−0.58% today
Market value
$85.88M
P/E ratio
3.3×last 12 months
200-week average
$17.2011% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Rallybio Corporation in more detail

RLYB trades at 3.3× its last twelve months' earnings, -2.8× next year's expected earnings, 197.9× sales. It sits 11% below its 200-week average of $17.20.

In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold RLYB, including Andreas Halvorsen (0.0% of the portfolio).

Superinvestors holding RLYB

1 of the investors tracked here report a position in their latest 13F filing.

Rallybio Corporation (RLYB): questions and answers

What is RLYB's P/E ratio?

Rallybio Corporation trades at 3.3× its last twelve months' earnings and -2.8× next year's expected earnings.

What is Rallybio Corporation's market cap?

Rallybio Corporation is valued at $85.88M at a share price of $15.34.

Is RLYB above its 200-week moving average?

No. RLYB is 10.8% below its 200-week average of $17.20. Long-term investors watch that line because strong companies rarely trade below it for long.

Does RLYB pay a dividend?

Rallybio Corporation does not currently pay a regular dividend.

Which famous investors own RLYB?

In their latest quarterly filings, Andreas Halvorsen (0.0% of the portfolio) hold RLYB. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Rallybio Corporation (RLYB) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/RLYB

Underlying data: Yahoo Finance; company filings with the SEC.